Correlation Between Artivion and Mangoceuticals, Common

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Artivion and Mangoceuticals, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artivion and Mangoceuticals, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Artivion and Mangoceuticals, Common Stock, you can compare the effects of market volatilities on Artivion and Mangoceuticals, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artivion with a short position of Mangoceuticals, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artivion and Mangoceuticals, Common.

Diversification Opportunities for Artivion and Mangoceuticals, Common

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Artivion and Mangoceuticals, is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Artivion and Mangoceuticals, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mangoceuticals, Common and Artivion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artivion are associated (or correlated) with Mangoceuticals, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mangoceuticals, Common has no effect on the direction of Artivion i.e., Artivion and Mangoceuticals, Common go up and down completely randomly.

Pair Corralation between Artivion and Mangoceuticals, Common

Given the investment horizon of 90 days Artivion is expected to generate 0.21 times more return on investment than Mangoceuticals, Common. However, Artivion is 4.87 times less risky than Mangoceuticals, Common. It trades about 0.11 of its potential returns per unit of risk. Mangoceuticals, Common Stock is currently generating about -0.02 per unit of risk. If you would invest  1,800  in Artivion on September 2, 2024 and sell it today you would earn a total of  1,152  from holding Artivion or generate 64.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Artivion  vs.  Mangoceuticals, Common Stock

 Performance 
       Timeline  
Artivion 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Artivion are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Artivion unveiled solid returns over the last few months and may actually be approaching a breakup point.
Mangoceuticals, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mangoceuticals, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Artivion and Mangoceuticals, Common Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Artivion and Mangoceuticals, Common

The main advantage of trading using opposite Artivion and Mangoceuticals, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artivion position performs unexpectedly, Mangoceuticals, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mangoceuticals, Common will offset losses from the drop in Mangoceuticals, Common's long position.
The idea behind Artivion and Mangoceuticals, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes